Delius Pharma Clocks 672.50% Q1 Growth, Eyes ₹350 Crores in FY25 Competitors Left Counting Dust
Mumbai, September, 19— Delius Pharmaceuticals Pvt Ltd, India’s fastest-rising bulk drug makers in the generics formulations space, has reported a 672.50% year-on-year revenue jump in Q1 FY 25-26, The sharp surge was driven by robust sales in its cephalosporin and ampicillin beta-lactam branded generics portfolio, expansion in branded generics, and the start of large-scale imports […]
Continue Reading